Carregando...

What have we learned from cancer immunotherapy in the last 3 years?

Until recently, most immunotherapeutic approaches used to fight cancer were ineffective, counteracted by the tumour’s ability to evade immune attack. However, extensive research has improved our understanding of tumour immunology and enabled the development of novel treatments that can harness the p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Ascierto, Paolo A, Marincola, Francesco M
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4038596/
https://ncbi.nlm.nih.gov/pubmed/24886164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-141
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!